27 results
Page 2 of 2
8-K
EX-99.1
0qhat9gk7p axsker
8 May 23
Zymeworks Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:13pm
10-K/A
1qi2a vfkpgpnuk8buc
28 Apr 23
Annual report (amended)
4:15pm
8-K
EX-99.1
h5bgo ynbna
18 Apr 23
ZW191 demonstrates strong responses in FRĪ±-low expressing patient-derived xenograft (PDX) models with favorable pharmacokinetic and safety profiles
4:18pm
8-K
EX-99.1
osg126k qo
10 Apr 23
Zymeworks Announces Appointment of Derek J. Miller to its Board of Directors
4:46pm
8-K
EX-99.1
mdcrrhw8oiori6s74c
21 Dec 22
Jazz Pharmaceuticals and Zymeworks Announce Jazz has Confirmed Opt-in and Advances Partnership for Zanidatamab
8:37am
DEF 14A
4tcm wf9gpio
25 Nov 22
Definitive proxy
6:16am